Parliamentary Panel to Hear Stakeholder Views on “Affordability of Cancer Treatment”


The House Health and Family Welfare Committee will meet for the second consecutive day on Tuesday to resume its discussion on “affordability of cancer treatment”. Chaired by Uttar Pradesh’s Samajwadi party leader and Rajya sabha MP Ram Gopal Yadav, the 28-member committee will hear “stakeholder views” at 11 a.m.

The committee had begun a discussion on “affordability of cancer treatment” on Monday evening attended by up to 28 members, including seven from the Rajya Sabha and 21 from the Lok Sabha. According to sources, during a nearly two-and-a-half-hour discussion on Monday, the Committee had suggested that the central government remove the GST on cancer drugs so that treatment for the genetic disease could be made affordable.

The committee also insisted on the issue of taking strict measures to control the prices of drugs and radiotherapy. In its meeting with Health Secretary Rajesh Bhushan and senior Health Ministry officials, the committee suggested making cancer a “notifiable disease”.

There has been a long standing demand to designate cancer as a reportable disease as this will have a huge impact and it will help to determine the exact incidence and prevalence of the disease and the use of appropriate resources to fight against it. disease. Aware of the fact that cancer treatment is very expensive, the committee stressed the need to check the overall pricing of cancer treatment.

Ministry of Health officials informed the committee that the National Pharmaceutical Pricing Authority (NPPA) has already set ceiling prices for 86 formulations and reduced the maximum retail price (MRP) for 526 brands of drugs used for cancer treatment up to 90%. The NPPA is a government regulatory body that controls the prices of pharmaceutical drugs. (ANI)

(This story has not been edited by the Devdiscourse team and is auto-generated from a syndicated feed.)

Previous Taruga launches auger program in copper and rare earth hunting
Next NTT DATA and Cogniac bring AI to manufacturing